Augmenting the microbiome
through fecal transplants (bacteriotherapy) is already a validated treatment for C. difficile colitis, a complication that can arise from antibiotic therapy.
The researchers found that aspects of the illness that were impacted
through fecal transplants included gastrointestinal transit (the time it takes for food to leave the stomach and travel through the intestine); intestinal barrier dysfunction; low grade inflammation; and anxiety - like behaviour.
The procedure, called a
fecal transplant, typically involves collecting and processing stool from a healthy relative and feeding it
through a nasal tube into the patient's small intestine.
«To preserve patient access to this treatment option, and given the scale that we've reached, demonstrating the safety and efficacy of
fecal transplantation through adequate and well - controlled clinical trials is the right thing to do,» explained Carolyn Edelstein, OpenBiome's director of Outreach and Public Affairs, in an op - ed published earlier today with the Fecal Transplant Founda
fecal transplantation
through adequate and well - controlled clinical trials is the right thing to do,» explained Carolyn Edelstein, OpenBiome's director of Outreach and Public Affairs, in an op - ed published earlier today with the
Fecal Transplant Founda
Fecal Transplant Foundation.